Expression of MHC class II antigens in human lung cancer cells

Virchows Arch B Cell Pathol Incl Mol Pathol. 1991;60(6):407-12. doi: 10.1007/BF02899573.

Abstract

Surgical specimens of lung cancers were examined immunopathologically for the expression of major histocompatibility complex class II (MHC-II) antigens in the tumor cells and their relationship to the lymphocytic infiltration. A lymphocytic infiltrate was frequently observed in the tumor tissue, though its intensity differed among the various histological types. MHC-II antigens were often demonstrated in tumors with a lymphocytic infiltrate. They were detected predominantly in the cytoplasm of tumor cells and to a lesser extent on the cell membranes. The emergence of the MHC-II-positive tumor cells was closely related to a local infiltration by lymphocytes including interferon-gamma (IFN-gamma)-producing T-cells. On the basis of the histological findings, an in vitro experiment was carried out. Four types of lung cancer cells were incubated with recombinant IFN-gamma in order to induce MHC-II antigens. MHC-II antigens (HLA-DR as well as HLA-DQ and HLA-DP antigens) were elicited in three cancer cell lines depending on the concentration of IFN-gamma. Immunoelectron microscopic study revealed that they were expressed on the surface of the cell membrane, though to a lesser extent than in the cytoplasm. It was considered that MHC-II antigens could be induced in some tumor cells in the immunological environment where IFN-gamma was secreted from T-cells and concentrated locally.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • HLA-DQ Antigens / analysis*
  • HLA-DR Antigens / analysis*
  • Humans
  • Inflammation / pathology
  • Interferon-gamma / pharmacology
  • Lung Neoplasms / pathology*
  • Lymphocytes / chemistry*
  • Recombinant Proteins
  • Tumor Cells, Cultured / drug effects

Substances

  • HLA-DQ Antigens
  • HLA-DR Antigens
  • Recombinant Proteins
  • Interferon-gamma